PGBD5 promotes site-specific oncogenic mutations in human tumors.
Henssen AG, Koche R, Zhuang J, Jiang E, Reed C, Eisenberg A, Still E, MacArthur IC, Rodriguez-Fos E, Gonzalez S, Puiggros M, Blackford AN, Mason CE, de Stanchina E, Gonen M, Emde AK, Shah M, Arora K, Reeves C, Socci ND, Perlman E, Antonescu CR, Roberts CWM, Steen H, Mullen E, Jackson SP, Torrents D, Weng Z, Armstrong SA, Kentsis A
Nat Genet. 2017 May 15. doi: 10.1038/ng.3866.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
ID | Plasmid | Purpose |
---|---|---|
78121 | pINDUCER21-PGBD5 | Lentiviral gene expression vector for doxycycline inducible PGBD5 expression |
80757 | pBS-EF1-IRES-NEO-Control | Transposon Reporter |
168053 | pRECLV103_PGBD5_B | Lentiviral expression vector for fusion of GFP with human PGBD5, NCBI: NM_001258311.1 |